Alter Ego holds a clear edge in trader sentiment for their MPL Indonesia regular season BO3 clash with Bigetron by Vitality, reflecting their 7-2 record compared to Bigetron's 4-5, including a dominant 2-0 head-to-head win earlier this season. Recent developments bolster this: Alter Ego rebounded with back-to-back sweeps against mid-table foes, showcasing strong macro play and hero versatility on the current patch, while Bigetron stumbled in a 1-2 loss to a playoff contender amid draft inconsistencies. No major roster changes reported, but Bigetron's home crowd could spark an upset; watch for early game tempo, as Alter Ego thrives in prolonged series. Odds imply 65% win probability for Alter Ego per crowd wisdom.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourBigetron by Vitality vs Alter Ego
This market will resolve to "Bigetron by Vitality" if Bigetron by Vitality win the match against Alter Ego.
This market will resolve to "Alter Ego" if Alter Ego win the match against Bigetron by Vitality.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/mobilelegends/Main_Page. However, if https://liquipedia.net/mobilelegends/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
Marché ouvert : Mar 22, 2026, 12:00 PM ET
Source de résolution
https://liquipedia.net/mobilelegends/Main_PageResolver
0x65070BE91...Bigetron by Vitality vs Alter Ego
This market will resolve to "Bigetron by Vitality" if Bigetron by Vitality win the match against Alter Ego.
This market will resolve to "Alter Ego" if Alter Ego win the match against Bigetron by Vitality.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/mobilelegends/Main_Page. However, if https://liquipedia.net/mobilelegends/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
Marché ouvert : Mar 22, 2026, 12:00 PM ET
Source de résolution
https://liquipedia.net/mobilelegends/Main_PageResolver
0x65070BE91...Alter Ego holds a clear edge in trader sentiment for their MPL Indonesia regular season BO3 clash with Bigetron by Vitality, reflecting their 7-2 record compared to Bigetron's 4-5, including a dominant 2-0 head-to-head win earlier this season. Recent developments bolster this: Alter Ego rebounded with back-to-back sweeps against mid-table foes, showcasing strong macro play and hero versatility on the current patch, while Bigetron stumbled in a 1-2 loss to a playoff contender amid draft inconsistencies. No major roster changes reported, but Bigetron's home crowd could spark an upset; watch for early game tempo, as Alter Ego thrives in prolonged series. Odds imply 65% win probability for Alter Ego per crowd wisdom.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour

Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes